Startseite>>Signaling Pathways>> Apoptosis>> PD-1/PD-L1 interaction>>PD-1/PD-L1-IN 3 TFA

PD-1/PD-L1-IN 3 TFA

Katalog-Nr.GC65071

PD-1/PD-L1-IN 3 TFA, ein makrozyklisches Peptid, ist ein potenter und selektiver Inhibitor der PD-1/PD-L1- und CD80/PD-L1-Wechselwirkungen, extrahiert aus dem Patent WO2014151634A1, Verbindung Nr. 1. PD-1/PD-L1-IN 3 TFA stÖrt die PD-L1-Bindung an PD-1 und CD80 durch Bindung an PD-L1 mit IC50-Werten von 5,60 nM bzw. 7,04 nM. PD-1/PD-L1-IN 3 TFA kann fÜr die Erforschung verschiedener Krankheiten, einschließlich Krebs und Infektionskrankheiten, verwendet werden.

Products are for research use only. Not for human use. We do not sell to patients.

PD-1/PD-L1-IN 3 TFA Chemische Struktur

Größe Preis Lagerbestand Menge
1mg
135,00 $
Auf Lager
5mg
405,00 $
Auf Lager
10mg
612,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PD-1/PD-L1-IN 3 TFA, a macrocyclic peptide, is a potent and selective inhibitor of the PD-1/PD-L1 and CD80/PD-L1 interactions extracted from patent WO2014151634A1, compound No.1. PD-1/PD-L1-IN 3 TFA interferes with PD-L1 binding to PD-1 and CD80 by binding to PD-L1, with IC50s of 5.60 nM and 7.04 nM, respectively. PD-1/PD-L1-IN 3 TFA can be used for the research of various diseases, including cancer and infectious diseases[1].

PD-1/PD-L1-IN 3 (0.1 nM-10 μM) inhibits the binding of PD-1 and CD80 to PD-L1, with IC50s of 5.60 nM and 7.04 nM[1].PD-1/PD-L1-IN 3 blocks the binding of recombinant PD-L1-Ig to Jurkat-PD-1 cells, and also block binding of recombinant PD-1-Ig to either L2987 or LK35.2-hPD-L1, with IC50s of 26 nM, 12 nM, and 3.5 nM, respectively[1].PD-1/PD-L1-IN 3 (0.001-100 μM) promotes IFN secretion by CMV-specific T cells in a dose-dependent manner, with an EC50 of 400 nM[1].

[1]. MILLER, Michael Matthew, et al. Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions. WO2014151634A1.

Bewertungen

Review for PD-1/PD-L1-IN 3 TFA

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PD-1/PD-L1-IN 3 TFA

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.